# FDA 483 - Long Island Jewish Medical Center - March 10, 2022

Source: https://www.keypedia.com/records/483/long-island-jewish-medical-center/4a0127ce-16fb-44a6-93fb-b6520ce5e471

> FDA 483 for Long Island Jewish Medical Center on March 10, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Long Island Jewish Medical Center
- Inspection Date: 2022-03-10
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: Long Island Jewish Medical Center in New Hyde Park, NY, was cited for two observations related to its blood bank operations. The inspection revealed deficiencies in written standard operating procedures for emergency blood release and computer downtime, leading to inconsistent record-keeping for blood product disposition. Additionally, the facility failed to maintain accurate storage and distribution records for blood units.

## Related Documents

- [483 - 2024-03-15](https://www.keypedia.com/records/483/long-island-jewish-medical-center/164661e2-970e-49d5-a92b-ee8838e5ad86)

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/long-island-jewish-medical-center/5a96c7ae-ca09-44a4-9c04-c05f5312d771

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961